Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging:: a quantitative MRI study

被引:38
作者
Bendszus, Martin [1 ,2 ]
Ladewig, Gesa [3 ]
Jestaedt, Leonie [1 ,2 ]
Misselwitz, Bernd [4 ]
Solymosi, Laszlo [2 ]
Toyka, Klaus [3 ]
Stoll, Guido [3 ]
机构
[1] Univ Heidelberg, Dept Neuroradiol, D-69120 Heidelberg, Germany
[2] Univ Wurzburg, Dept Neuroradiol, D-97070 Wurzburg, Germany
[3] Univ Wurzburg, Dept Neurol, D-97070 Wurzburg, Germany
[4] Bayer Schering Pharma AG, Res Labs, Berlin, Germany
关键词
multiple sclerosis; CNS inflammation; experimental autoimmune encephalomyelitis; magnetic resonance imaging; Gadofluorine;
D O I
10.1093/brain/awn156
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Magnetic resonance imaging plays a pivotal role in the diagnosis and treatment monitoring of multiple sclerosis. Currently available magnetic resonance-techniques only partly reflect the extent of tissue inflammation and damage. In the present study, application of the experimental magnetic resonance-contrast agent Gadofluorine M significantly increased the sensitivity of lesion detection in myelin-oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis. Gadofluorine M-enhancement on T(1)-weighted (T(1)-w) images utilizing a clinical 1.5 T magnetic resonance unit showed numerous lesions in optic nerve, spinal cord and brain, the majority of which were not detectable on standard T(2)-weighted (T(2)-w) and Gd-DTPA enhanced T(1)-w sequences. Quantitative assessment by pixel counts revealed highly significant differences in sensitivity in favour of Gadofluorine M. Gadofluorine uptake closely corresponded to inflammation and demyelination on tissue sections. These unique features of Gadofluorine M in visualizing inflammatory CNS lesions hold promise for future clinical development in multiple sclerosis.
引用
收藏
页码:2341 / 2352
页数:12
相关论文
共 26 条
[1]   Detection of atherosclerotic plaque with gadofluorine-enhanced magnetic resonance imaging [J].
Barkhausen, J ;
Ebert, W ;
Heyer, C ;
Debatin, JF ;
Weinmann, HJ .
CIRCULATION, 2003, 108 (05) :605-609
[2]   Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis [J].
Barkhof, F ;
Filippi, M ;
Miller, DH ;
Scheltens, P ;
Campi, A ;
Polman, CH ;
Comi, G ;
Ader, HJ ;
Losseff, N ;
Valk, J .
BRAIN, 1997, 120 :2059-2069
[3]   Assessment of nerve degeneration by gadofluorine M-enhanced magnetic resonance imaging [J].
Bendszus, M ;
Wessig, C ;
Schütz, A ;
Horn, T ;
Kleinschnitz, C ;
Sommer, C ;
Misselwitz, B ;
Stoll, G .
ANNALS OF NEUROLOGY, 2005, 57 (03) :388-395
[4]  
Bendszus M, 2003, J NEUROSCI, V23, P10892
[5]   Iron-enhanced MRI in ischemic stroke: Intravascular trapping versus cellular inflammation [J].
Bendszus, Martin ;
Kleinschnitz, Christoph ;
Stoll, Guido .
STROKE, 2007, 38 (05) :E12-E12
[6]   Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions [J].
Bergers, E ;
Bot, JCJ ;
De Groot, CJA ;
Polman, CH ;
Nijeholt, GJLA ;
Castelijns, JA ;
van der Valk, P ;
Barkhof, F .
NEUROLOGY, 2002, 59 (11) :1766-1771
[7]   Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE [J].
Brochet, B. ;
Deloire, M. S. A. ;
Touil, T. ;
Anne, O. ;
Caille, J. M. ;
Dousset, V. ;
Petry, K. G. .
NEUROIMAGE, 2006, 32 (01) :266-274
[8]   Effect of early interferon treatment on conversion to definite multiple sclerosis:: a randomised study [J].
Comi, G ;
Filippi, M ;
Barkhof, F ;
Durelli, L ;
Edan, G ;
Fernández, O ;
Hartung, HP ;
Seeldrayers, P ;
Sorensen, PS ;
Rovaris, M ;
Martinelli, V ;
Hommes, OR .
LANCET, 2001, 357 (9268) :1576-1582
[9]   Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide [J].
Devaux, B ;
Enderlin, F ;
Wallner, B ;
Smilek, DE .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 75 (1-2) :169-173
[10]  
Dousset V, 2006, AM J NEURORADIOL, V27, P1000